Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Translational Medicine
|
February 12, 2026
Increased IL4I1 expression predicts poor survival and modulates the immune microenvironment in acute myeloid leukemia
Jinlong Huang, Jinyuan Chen, Liangyong Yang, et al.
Frontiers in Immunology
|
October 27, 2025
Prognostic genes related to mitochondrial dynamics and mitophagy in diffuse large B-cell lymphoma are identified and validated using an integrated analysis of bulk and single-cell RNA sequencing
Qingjiao Chen, Mingui Chen, Jizhen Wang, et al.
American Journal of Hematology
|
April 26, 2026
Multicenter Real-World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics
Apeng Yang, Jinfeng Dong, Xiaofang Deng, et al.
Signal Transduction and Targeted Therapy
|
September 3, 2024
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
Zhiyong Zeng, Apeng Yang, Jingke Yang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Translational Medicine
|
February 12, 2026
Increased IL4I1 expression predicts poor survival and modulates the immune microenvironment in acute myeloid leukemia
Jinlong Huang, Jinyuan Chen, Liangyong Yang, et al.
Frontiers in Immunology
|
October 27, 2025
Prognostic genes related to mitochondrial dynamics and mitophagy in diffuse large B-cell lymphoma are identified and validated using an integrated analysis of bulk and single-cell RNA sequencing
Qingjiao Chen, Mingui Chen, Jizhen Wang, et al.
American Journal of Hematology
|
April 26, 2026
Multicenter Real-World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics
Apeng Yang, Jinfeng Dong, Xiaofang Deng, et al.
Signal Transduction and Targeted Therapy
|
September 3, 2024
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
Zhiyong Zeng, Apeng Yang, Jingke Yang, et al.
Page
of 6